3. Extracorporeal membrane oxygenation for Covid-19 associated severe acute respiratory distress syndrome

Tran Huyen Trang, Nguyen Tat Thanh, Nguyen Minh Nguyen, Nguyen Anh Dung, Hoang Bui Hai

Nội dung chính của bài viết

Tóm tắt

COVID-19  caused significant mortality worldwide, including in Vietnam. This study aimed to evaluate the effectiveness of Extracorporeal membrane oxygenation (ECMO) in the treatment of COVID-19 patients with acute respiratory distress syndrome (ARDS). From January 1, 2022 to March 31, 2022, the COVID-19 hospital admitted 395 critical patients, including 10 patients required veno-venous Extracorporeal membrane oxygenation (VV-ECMO). This descriptive study revealed relatively high survival rate of 60% (6/10 patients) with the median duration of ECMO was 11.5 days. The study group's SOFA and RESP scores were 6 and 4, respectively. Time from symptom onset to mechanical ventilation, duration of NIV and/or HFNC before mechanical ventilation, time from symptom onset to ECMO of the study patients were 9.5, 0 and 11.5 days, respectively. The most common complication in ECMO patients was nosocomial infection (70%), in addition to bleeding, embolism, or both at the same time. This preliminary research showed that ECMO was effective in the management of acute respiratory distress syndrome in patients with COVID-19.

Chi tiết bài viết

Tài liệu tham khảo

1. Mahendra M, Nuchin A, Kumar R, Shreedhar S, Mahesh PA. Predictors of mortality in patients with severe COVID-19 pneumonia - a retrospective study. Adv Respir Med. 2021; 89(2): 135-144.
2. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020; 395(10229): 1054-1062.
3. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory medicine. 2020; 8(5): 475-481.
4. Dognon N, Gaudet A, Parmentier-Decrucq E, et al. Extracorporeal Membrane Oxygenation for COVID 2019-Acute Respiratory Distress Syndrome: Comparison between First and Second Waves (Stage 2). Journal of clinical medicine. 2021; 10(21).
5. Badulak J, Antonini MV, Stead CM, et al. Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization. ASAIO journal (American Society for Artificial Internal Organs : 1992). 2021; 67(5): 485-495.
6. Li X, Hu M, Zheng R, et al. Delayed Initiation of ECMO Is Associated With Poor Outcomes in Patients With Severe COVID-19: A Multicenter Retrospective Cohort Study. Front Med (Lausanne). 2021; 8: 716086.
7. Ramanathan K, Shekar K, Ling RR, et al. Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis. Crit Care. 2021; 25(1): 211.
8. Hall CA, Jacobs JP, Stammers AH, et al. Multi-institutional Analysis of 505 COVID-19 Patients Supported with ECMO: Predictors of Survival. Ann Thorac Surg. 2022.
9. Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of Coronavirus Disease 2019. Critical care medicine. 2020; 48(9): 1358-1364.
10. Durak K, Kersten A, Grottke O, et al. Thromboembolic and Bleeding Events in COVID-19 Patients receiving Extracorporeal Membrane Oxygenation. The Thoracic and cardiovascular surgeon. 2021; 69(6): 526-536.
11. Ripoll B, Rubino A, Besser M, et al. Observational study of thrombosis and bleeding in COVID-19 VV ECMO patients. The International journal of artificial organs. 2022; 45(2): 239-242.
12. Hermann M, Laxar D, Krall C, et al. Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Annals of Intensive Care. 2022; 12(1): 6.
13. Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ (Clinical research ed). 2020; 369:m1966.
14. Marcus JE, Sams VG, Barsoumian AE. Elevated secondary infection rates in patients with coronavirus disease 2019 (COVID-19) requiring extracorporeal membrane oxygenation. Infection control and hospital epidemiology. 2021; 42(6): 770-772.
15. Diaz RA, Graf J, Zambrano JM, et al. Extracorporeal Membrane Oxygenation for COVID-19-associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study. American journal of respiratory and critical care medicine. 2021; 204(1): 34-43.